Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Fabbrini

Showing results (1-10 of 235) with videos related to

Pageof 24
Sort By:
Archives of Neurology|April 21, 2004
Migraine and Tourette syndromePiero Barbanti, Giovanni Fabbrini
Handbook of Clinical Neurology|September 24, 2008
Investigational drugsCarlo Colosimo, Giovanni Fabbrini
Nature Clinical Practice. Neurology|October 24, 2006
Drug Insight: new drugs in development for Parkinson's diseaseCarlo Colosimo, Giovanni Fabbrini, Alfredo Berardelli
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 26, 2018
Language use at Italian medical congressesGiovanni Fabbrini, Antonella Conte, Alfredo Berardelli
Handbook of Clinical Neurology|November 16, 2019
Progressive supranuclear palsy, multiple system atrophy and corticobasal degenerationGiovanni Fabbrini, Andrea Fabbrini, Antonio Suppa
Clinical Neuropharmacology|May 18, 2012
Selegiline: a reappraisal of its role in Parkinson diseaseGiovanni Fabbrini, Giovanni Abbruzzese, Stefano Marconi, et al.
Frontiers in Neurology|April 2, 2014
Parkinsonian patients and poor awareness of dyskinesiasSara Pietracupa, Anna Latorre, Alfredo Berardelli, et al.
Rivista Di Psichiatria|April 15, 2022
[Neuropsychiatry as the interface of behavioral manifestations driven by brain dysfunction.]Massimo Pasquini, Isabella Berardelli, Massimo Biondi, et al.
Journal of Neurology|November 17, 2010
Soluble and controlled-release preparations of levodopa: do we really need them?Giovanni Fabbrini, Flavio Di Stasio, Maria Bloise, et al.
Expert Review of Neurotherapeutics|June 12, 2014
The role of subcutaneous infusion of apomorphine in Parkinson's diseaseKaroline Wenzel, Carl Nikolaus Homann, Giovanni Fabbrini, et al.
Pageof 24

Showing results (1-10 of 235) with videos related to

Sort By:
Pageof 24
Archives of Neurology|April 21, 2004
Migraine and Tourette syndromePiero Barbanti, Giovanni Fabbrini
Handbook of Clinical Neurology|September 24, 2008
Investigational drugsCarlo Colosimo, Giovanni Fabbrini
Nature Clinical Practice. Neurology|October 24, 2006
Drug Insight: new drugs in development for Parkinson's diseaseCarlo Colosimo, Giovanni Fabbrini, Alfredo Berardelli
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 26, 2018
Language use at Italian medical congressesGiovanni Fabbrini, Antonella Conte, Alfredo Berardelli
Handbook of Clinical Neurology|November 16, 2019
Progressive supranuclear palsy, multiple system atrophy and corticobasal degenerationGiovanni Fabbrini, Andrea Fabbrini, Antonio Suppa
Clinical Neuropharmacology|May 18, 2012
Selegiline: a reappraisal of its role in Parkinson diseaseGiovanni Fabbrini, Giovanni Abbruzzese, Stefano Marconi, et al.
Frontiers in Neurology|April 2, 2014
Parkinsonian patients and poor awareness of dyskinesiasSara Pietracupa, Anna Latorre, Alfredo Berardelli, et al.
Rivista Di Psichiatria|April 15, 2022
[Neuropsychiatry as the interface of behavioral manifestations driven by brain dysfunction.]Massimo Pasquini, Isabella Berardelli, Massimo Biondi, et al.
Journal of Neurology|November 17, 2010
Soluble and controlled-release preparations of levodopa: do we really need them?Giovanni Fabbrini, Flavio Di Stasio, Maria Bloise, et al.
Expert Review of Neurotherapeutics|June 12, 2014
The role of subcutaneous infusion of apomorphine in Parkinson's diseaseKaroline Wenzel, Carl Nikolaus Homann, Giovanni Fabbrini, et al.
Pageof 24